Repare Therapeutics Inc. Proceeds from Common Stock Issued
Repare Therapeutics Inc. reported Proceeds from Common Stock Issued of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-28.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2023-02-28
- Repare Therapeutics Inc. proceeds from issuance of common stock for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Repare Therapeutics Inc. proceeds from issuance of common stock for fiscal 2021 was $94.29M.
| Period end | Proceeds from Issuance of Common Stock 12 month |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2021-12-31 | $94.29M 10-K · filed 2023-02-28 |